Topic teaching:The Hype and Hope of Gene Therapy for Patients with Sickle Cell Disease

Presented by

Dr. Kevin H.M. Kuo, MD, MSc, FRCPC 

Associate Professor 

Division of Hematology, Department of Medicine, Faculty of Medicine, University of Toronto 

Associate Professor (status) 

Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto 

Learning objectives

1. Review the clinical evidence that led to the approval of gene therapy for patients with sickle cell disease in Canada 

2. Discuss the potential risks and uncertainties with gene therapy  

3. Explore the logistical challenges with deploying gene therapy in Canada

Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Registration

Closed

Appraisal

Closed

To be added to the distribution list for the LearnTransfusion series, send an email to learn.transfusion@blood.ca  with “Weekly Transfusion Medicine Seminars” in the subject line. Include your name and complete e-mail address in the body of the e-mail and confirm that you would like to be added to the distribution list for the LearnTransfusion series. You will then receive weekly email notifications of upcoming series events with details on how to join the webinars (e.g.,  link to register for the webinar).

The LearnTransfusion series is the seminar component of the Areas of Focused Competency (AFC)-Diploma Program in Transfusion Medicine. The series, organized by Canadian Blood Services, is also open to all practitioners in the field of Transfusion Medicine. Through a series of regular webinars, trainees and practitioners are exposed to various scientific, technical and clinical aspects of transfusion medicine.